Hudson Bay Capital Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.2M Sell
260,000
-15,000
-5% -$1.41M 0.07% 199
2026
Q1
$24.4M Sell
275,000
-100,000
-27% -$10.3M 0.08% 171
2025
Q4
$35.7M Buy
375,000
+169,996
+83% +$17.1M 0.12% 156
2025
Q3
$20.2M Buy
205,004
+55,004
+37% +$5.88M 0.07% 220
2025
Q2
$16M Sell
150,000
-15,000
-9% -$1.52M 0.05% 253
2025
Q1
$15M Buy
165,000
+35,000
+27% +$3.92M 0.05% 313
2024
Q4
$14.8M Hold
130,000
0.05% 289
2024
Q3
$15.4M Sell
130,000
-216,600
-62% -$19.9M 0.06% 199
2024
Q2
$27.9M Buy
346,600
+176,600
+104% +$16.1M 0.13% 109
2024
Q1
$15.7M Buy
170,000
+80,000
+89% +$7.67M 0.09% 123
2023
Q4
$9.5M Buy
90,000
+35,000
+64% +$3.53M 0.06% 188
2023
Q3
$5.98M Sell
55,000
-25,000
-31% -$2.76M 0.05% 250
2023
Q2
$8.63M Buy
80,000
+40,000
+100% +$4.5M 0.06% 195
2023
Q1
$4.98M Buy
+40,000
New +$5.49M 0.04% 316
2022
Q4
Sell
-10,000
Closed -$1.35M 999
2022
Q3
$1.35M Buy
10,000
+2,500
+33% +$382K 0.01% 810
2022
Q2
$1.12M Sell
7,500
-15,000
-67% -$2.29M 0.01% 905
2022
Q1
$3.84M Buy
+22,500
New +$3.78M 0.05% 484
2020
Q2
Sell
-20,000
Closed -$1.17M 493
2020
Q1
$1.17M Buy
+20,000
New +$778K 0.03% 310

Other funds holding BNTX

Hudson Bay Capital Management's BNTX Position: Q2 2026 in Review

Hudson Bay Capital Management reduced its BioNTech (BNTX) stake by 5.5% in Q2 2026, selling an estimated $1.41M and leaving 260,000 shares worth $24.2M. The position accounts for 0.07% of the portfolio, ranked #199.

Hudson Bay Capital Management first reported a position in BNTX in Q1 2020 and has held it in 18 quarters since. The position peaked at $35.7M in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Hudson Bay Capital Management held 260,000 shares of BioNTech worth $24.2M as of Q2 2026.
  • Hudson Bay Capital Management sold 15,000 BioNTech shares in Q2 2026, an estimated $1.41M.
  • BioNTech made up 0.07% of Hudson Bay Capital Management's portfolio in Q2 2026, its #199 holding.
  • Hudson Bay Capital Management first reported a position in BioNTech in Q1 2020 and has held it in 18 quarters since.
  • Hudson Bay Capital Management's BioNTech position peaked at $35.7M in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.